Evidence map›Paper›PMID 16814734›Full record

ArticleCell metabolism2006

Role of adiponectin in human skeletal muscle bioenergetics.

Anthony E Civitarese, Barbara Ukropcova, Stacy Carling, Matthew Hulver, Ralph A DeFronzo, Lawrence Mandarino, Eric Ravussin, Steve R Smith

Registry-linked trialOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in Cell metabolism, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01431677 (Muscle Biopsies in Healthy Volunteers), which is not on this map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01431677 naterminatednot on this mapstarted 2010, after this paper: background citation

Muscle Biopsies in Healthy Volunteers: a Pilot Study

TypeinterventionalSponsorNational Institute on Aging (NIA)Ran2010 to 2014Enrolled22ConditionsSarcopenia, Frailty, AgingArmsMuscle Biopsy
3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 228 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Adiponectin gene therapy prevents islet loss after transplantation.Journal of cellular and molecular medicine · 2022
    Article
  19. Humanin and diabetes mellitus: A review ofWorld journal of diabetes · 2022
    Review
  20. Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Anthony E CivitaresePennington Biomedical Research Center, Baton Rouge, Louisiana 70808, USA.
Barbara Ukropcova
Stacy Carling
Matthew Hulver
Ralph A DeFronzo
Lawrence Mandarino
Eric Ravussin
Steve R Smith
University of Pennsylvania · USPennington Biomedical Research Center · USThe University of Texas Health Science Center at San Antonio · US

Funding

Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2005 to 2026
$26.5M
ZOLEDRONATE VS AREDIA IN MULTIPLE MYELOMA/BREAST CANCER W /BONE DISORDERSM01RR001346 · NCRR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FERRER, ROBERT L · 1985 to 2008
$23.1M
Metabolic Adaptations to Two Year Caloric RestrictionU01AG020478 · NIA · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI RAVUSSIN, ERIC · 2002 to 2008
$13.4M
SGLT2 Inhibitors, Ketogenesis, and KetoacidosisR01DK024092 · NIDDK · YALE UNIVERSITY · PI RALPH A DEFRONZO · 1986 to 2026
$12.7M
PGC-1 & Muscle Mitochondrial Dysfunction in DiabetesR01DK066483 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI MANDARINO, LAWRENCE J · 2004 to 2018
$6.7M
Regulation of Hepatic and Peripheral Glucose MetabolismR56DK024092 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI DEFRONZO, RALPH A · 2005 to 2005
$73k
NCRR NIH HHS M01 RR001346NCRR NIH HHS M01RR001346NIA NIH HHS R01 AG20478NIA NIH HHS U01 AG020478NIDDK NIH HHS DK04796NIDDK NIH HHS DK066483NIDDK NIH HHS DK24092NIDDK NIH HHS P30 DK072476NIDDK NIH HHS R01 DK024092NIDDK NIH HHS R01 DK066483NIDDK NIH HHS R56 DK024092
6 · The paper itself

Abstract

Insulin resistance is associated with impaired skeletal muscle oxidation capacity and reduced mitochondrial number and function. Here, we report that adiponectin signaling regulates mitochondrial bioenergetics in skeletal muscle. Individuals with a family history of type 2 diabetes display skeletal muscle insulin resistance and mitochondrial dysfunction; adiponectin levels strongly correlate with mtDNA content. Knockout of the adiponectin gene in mice is associated with insulin resistance and low mitochondrial content and reduced mitochondrial enzyme activity in skeletal muscle. Adiponectin treatment of human myotubes in primary culture induces mitochondrial biogenesis, palmitate oxidation, and citrate synthase activity, and reduces the production of reactive oxygen species. The inhibition of adiponectin receptor expression by siRNA, or of AMPK by a pharmacological agent, blunts adiponectin induction of mitochondrial function. Our findings define a skeletal muscle pathway by which adiponectin increases mitochondrial number and function and exerts antidiabetic effects.

Indexed as

AdiponectinAdultAnimalsCells, CulturedDiabetes Mellitus, Type 2DNA, MitochondrialEnergy MetabolismFemaleHumansInsulin ResistanceMaleMiceMice, Inbred C57BLMice, KnockoutMitochondriaMuscle CellsAdiponectinADIPOR1 protein, humanADIPOR2 protein, humanDNA, MitochondrialReactive Oxygen SpeciesReceptors, AdiponectinReceptors, Cell Surface

Identifiers

PMID16814734
PMCPMC2671025
OpenAlexW2084362716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.